Amidst the distress caused by a cancer diagnosis, patients are left to sort through vast amounts of information, treatment options, and concerns around efficacy and side effects, while juggling other life activities.
This test can be thought of as a crystal ball for cancer survivors and research has found it can predict with near certainty whether a patient’s cancer will recur. So why aren't more patients getting the test?
Break down the silos. Take control of your provider data.
AI startup Paige launched an AI-powered biomarker module that the company says can evaluate more than 505 genes and identify 1,228 molecular biomarkers from standard pathology slides.
Prenuvo — a company that makes an MRI machine that performs quick whole-body scans — closed a $70 million Series A equity and debt funding round. It will use the money to open more clinics throughout the country, as well as find ways to make its price point more accessible.
When breast cancer spreads, it commonly invades the lymph nodes—structures that are part of the body's immune system. Paige's software is designed to find cancer in the lymph nodes that might otherwise be missed, like tiny collections of cancer cells called micrometastases.
Researchers at MIT are looking to make cancer cell imaging not only much less expensive, but also much more convenient for testing in different parts of the world.
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.